ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Obey Continue Crusade On Carcinogenesis, Attack On DCCP, Shubik

April 1, 1977

New Concept For Prevention Units Goes to DCPC BSC

April 24, 1987

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

DCT Board Approves Major Clinical Trials Changes, Regional Groups, New Effort In Surgical Oncology

October 10, 1980

Duke Plans To Restart Three Trials Using Tumor Microarray Analysis

January 29, 2010

NCCN Admits Two New Member Institutions

March 22, 2013